ACELYRIN INC. - COMMON STOCK

3.1300

26-December-24 10:06:35

15 minutes delayed

Stocks

-0.0400

-1.26%

Today's range

3.1000 - 3.1650

ISIN

N/A

Source

NASDAQ

ACELYRIN, INC. Provides Update on Izokibep Clinical Development Program

27 Nov 2023 16:30:00 By Nasdaq GlobeNewswire
ACELYRIN, INC. Reports Third Quarter 2023 Financial Results and Recent Highlights

07 Nov 2023 16:05:00 By Nasdaq GlobeNewswire
ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer

06 Nov 2023 07:00:00 By Nasdaq GlobeNewswire
ACELYRIN, INC. to Report Third Quarter 2023 Financial Results and Corporate Update on November 7, 2023

31 Oct 2023 16:30:00 By Nasdaq GlobeNewswire
ACELYRIN, INC. Scales for Continued Late-Stage Growth with The Appointment of Dr. Shephard Mpofu as Senior Vice President of Development

03 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa

11 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.